CD8+ T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity

Autoimmunity

Volumn 44, Issue 1, 2011, Pages 51-57

  Filaci, Gilberto ^a   Fenoglio, Daniela ^a   Indiveri, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmunity; CD8+ Treg; IL10; TGF ; Tolerance

Indexed keywords

ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UVEORETINITIS;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; MICE; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS;

EID: 78751547636     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916931003782171     Document Type: Review

References (78)

1. Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971;21:903-914.
2. Moller G. Do suppressor T cells exist? Scand J Immunol 1988; 27:247-250.
3. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000;101:455-458.
4. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell clonal deletion. Immunity 2000;13: 829-840.
5. Moudgil KD, Sercarz EE. The self-directed T cell repertoire: Its creation and activation. Rev Immunogenetics 2000;2: 26-37.
6. Maverakis E, van den Elzen P, Sercarz EE. Self-reactive T cells and degeneracy of T cell recognition: Evolving concepts-from sequence homology to shape mimicry and TCR flexibility. J Autoimmun 2001;16:201-209.
7. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994;12:991-1045.
8. Konya C, Goronzy JJ, Weyand CM. Treating autoimmune disease by targeting CD8+ T suppressor cells. Expert Opin Biol Ther 2009;9:951-965.
9. Smith TRF, Kumar V. Revival of CD8+ Treg mediated suppression. Trends Immunol 2008;29:337-342.
10. Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B, Santarlasci V,Manetti R, Vanini V, Romagnani P, Maggi E, Romagnani S, Annunziato F. Human CD8+ CD25+ thymocytes share phenotypic and functional features with CD4+ CD25+ regulatory thymocytes. Blood 2003;102: 4107-4114.
11. Maggi E, Cosmi L, Liotta F, Romagnani P, Romagnani S, Annunziato F. Thymic regulatory T cells. Autoimmun Rev 2005;4:579-586.
12. Bienvenu B, Martin B, Auffray C, Cordier C, Bécourt C, Lucas B. Peripheral CD8+ CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 2005;175:246-253.
13. Endharti AT, RifaI M, Shi Z, Fukuoka Y, Nakahara Y, Kawamoto Y, Takeda K, Isobe K, Suzuki H. Cutting edge: CD8+ CD122+ regulatory T cells produce IL-10 to suppress IFN-g production and proliferation of CD8+ T cells. J Immunol 2005;175:7093-7097.
14. Rifai M, Shi Z, Zhang SY, Lee YH, Shiku H, Isobe K, Suzuki H. CD8+ CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-ab TCR interaction and become IL-10-producing active regulatory cells. Int Immunol 2008;20:937-947.
15. Miyara M, Sakaguchi S. Natural regulatory T cells: Mechanisms of suppression. Trends Mol Med 2007;13: 108-116.
16. Jiang H, Braunstein NS, Yu B, Winchester R, Chess L. CD8+ T cells control the Th phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc Natl Acad Sci USA 2001;98: 6301-6316.
17. Feger U, Tolosa E, Huang Y-H,Waschbisch A, Biedermann T, Melms A, Wiendl H. HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood 2007;110:568-577.
18. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-787.
19. Jiang H, Chess L. Qa-1/HLA-E-restricted regulatory CD8+ T cells and self-nonself discrimination: An essay on peripheral T-cell regulation. Hum Immunol 2008;69:721-727.
20. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005;6:1142-1151.
21. Bautista JL, Lio CW, Lathrop SK, Forbush K, Liang Y, Luo J, Rudensky AY, Hsieh CS. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol 2009;10:610-617.
22. Qin H, Vlad G, Cortesini R, Suciu-Foca N, Manavalan JS. CD8+ suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide. Hum Immunol 2008;69:776-780.
23. Rifai M, Kawamoto Y, Nakashima I, Suzuki H. Essential roles for CD8+ CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004;200:1123-1134.
24. Lee YH, Ishida Y, Rifai M, Shi Z, Isobe K, Suzuki H. Essential roles for CD8+ CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 2008;180:825-832.
25. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR, Jr, MullerW, Rudensky AY. Regulatory T cell derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008;28:546-558.
26. Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F. Non-antigen specific CD8+ T suppressor lymphocytes originate from CD8+ CD28+ T cells and inhibit both T cell proliferation and CTL function. Hum Immunol 2004;65:142-156.
27. Suzuki M, Konya C, Goronzy JJ, Weyand CM. Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol 2008; 69:781-789.
28. Mahic M, Henjum K, Yakub S, Bjornbeth BA, Torgersen KM, Tasken K, Aandahl EM. Generation of highly suppressive adaptive CD8+ CD25+ FOXP3+ regulatory T cells by continuous antigen stimulation. Eur J Immunol 2008;38: 640-646.
29. Ben-David H, Sharabi A, Dayan M, Sela M, Mozes E. The role of CD8+ CD282 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand. Proc Natl Acad Sci USA 2007;104:17459-17464.
30. Ciubotariu R, Colovai AI, Pennesi G, Liu Z, Smith D, Berlocco P, Cortesini R, Suciu-FocaN. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+ CD282 regulatory T cells. J Immunol 1998;161: 5193-5202.
31. Jarvis LB, Matyszak MK, Duggleby RC, Goodall JC, Hall FC, Gaston JS. Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. Eur J Immunol 2005;35:2896-2908.
32. Singh RR. SLE: Translating lessons from models system to human disease. Trends Immunol 2005;26:572-579.
33. Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: Role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008;223:371-390.
34. Filaci G, Bacilieri S, Fravega M, Monetti M, Contini P, Ghio M, Setti M, Puppo F, Indiveri F. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J Immunol 2001;166:6452-6457.
35. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003;21:273-276. (Pubitemid 37410115)
36. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debré P, Piette JC, Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005;175:8392-8400.
37. Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007;178: 2579-2588.
38. Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, Fiehn C, Ho AD, Lorenz HM. Reduced CD4+, CD252 T cell sensitivity to the suppressive function of CD4+, CD25high, CD1272/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008;58:2120-2130.
39. Singh RP, Hahn BH, La Cava A. Tuning immune suppression in systemic autoimmunity with self-derived peptides. Inflamm Allergy Drug Targets 2008;7:253-259.
40. La Cava A, Ebling FM, Hahn BH. Ig-Reactive CD4+ CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 2004;173:3542-3548.
41. Hahn BH, Singh RP, La Cava A, Ebling FM. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFb secreting CD8+ T cell suppressors. J Immunol 2005;175:7728-7737.
42. Skaggs BJ, Singh RP, Hahn BH. Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice. Hum Immunol 2008;69:790-796.
43. Kang HK, Michaels MA, Berner BR, Datta SK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol 2005; 174:3247-3255.
44. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4+ CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004;50:2775-2785.
45. Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V. CD25 brightCD41 regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004;6:R335-R346.
46. Mottonen M, Helkkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005;140:360-367.
47. Klimiuk PA, Goronzy JJ, Weyand CM. IL-16 as an antiinflammatory cytokine in rheumatoid synovitis. J Immunol 1999;162:4293-4299.
48. Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, Goronzy JJ, Weyand CM. Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. J Immunol 2005;174:7292-7301.
49. Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, Suh JH, Choi BK, Vinay DS, Kwon BS. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 2004;10: 1088-1094.
50. Balashov KE, Khoury SJ, Hafler DA, Weiner HL. Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-g and is defective in chronic progressive multiple sclerosis. J Clin Invest 1995;95: 2711-2719.
51. Tennakoon DK, Mehta RS, Ortega SB, Bhoj V, Racke MK, Karandikar NJ. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J Immunol 2006;176: 7119-7129.
52. Villa Correale J. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008; 195:121-134.
53. Biegler BW, Yan SX, Ortega SB, Tennakoon DK, Racke MK, Karandikar NJ. Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis. J Neuroimmunol 2006;180:159-171.
54. Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H. Specific central nervous system recruitment of HLA-G+ regulatory T cells in multiple sclerosis. Ann Neurol 2009;66:171-183.
55. Jiang H, Zhang SI, Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992;256: 1213-1215.
56. Montero E, Nussbaum G, Kaye JF, Perez R, Lage A, Ben-Nun A, Cohen IR. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: Analysis using depleting antibodies. J Autoimmun 2004;23: 1-7.
57. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 2004;5:516-523.
58. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor b after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89: 21-435.
59. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+ CD25+ Tregs. J Clin Invest 2005;115:2904-2913.
60. Wang R, Han G, Song L,Wang J, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y. CD8+ regulatory T cells are responsible for GAD-IgG gene-transferred tolerance induction in NOD mice. Immunology 2009;126:123-131.
61. Filaci G, Fravega M, Fenoglio D, Rizzi M, Negrini S, Viggiani R, Indiveri F. Non-antigen specific CD8+ T suppressor lymphocytes. Clin Exp Med 2004;4:86-92.
62. Filaci G, Rizzi M, Setti M, Fenoglio D, Fravega M, Basso M, Ansaldo G, Ceppa P, Borgonovo G, Murdaca G, Ferrera F, Picciotto A, Fiocca R, Torre G, Indiveri F. Non-antigenspecific CD8+ T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci 2005;1050:115-123.
63. Saitoh O, Abiru N, Nakahara M, Nagayama Y. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves hyperthyroidism in a murine model. Endocrinology 2007;148:6040-6046.
64. Zhang L, Jarvis LB, Baek HJ, Gaton JS. Regulatory IL4+ CD8+ T cells in patients with ankylosng spondylitis and healthy controls. Ann Rheum Dis 2009;68:1345-1351.
65. Choi BK, Asai T, Vinay DS, Kim YH, Kwon BS. 4-1BBmediated amelioration of experimental autoimmune uveoretinitis is caused by indoeamine 2,3-dioxygenase-dependent mechanisms. Cyokine 2006;34:233-242.
66. Vlad G, Coresini R, Suciu-Foca N. CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol 2008;69: 681-686.
67. Uss E, Rowshani AT, Hooibrink B, Lardy NM, van Lier RA, ten Berge I. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J Immunol 2006;177:2775-2783.
68. Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002;195:695-704.
69. Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, ZouW. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005;65:5020-5026.
70. Gray JD, Hirokawa M, Ohtsuka K, Horwitz DA. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-b: Contrasting effects of anti-CD2 and anti-CD3. J Immunol 1998;160:2248-2254.
71. Billerbeck E, Blum HE, Thimme R. Parallel expansion of human virus-specific FoxP32 effector memory and de novogenerated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J Immunol 2007;179:1039-1048.
72. Joosten SA, van Meijgaarden KE, Savage ND, de Boer T, Triebel F, van der Wal A, de Heer E, Klein MR, Geluk A, Ottenhoff TH. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci USA 2007;104: 8029-8034.
73. Ménager-Marcq I, Pomié C, Romagnoli P, van Meerwijk JP. CD8+ CD282 regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006;131:1775-1785.
74. Zheng SG, Wang JH, Koss MN, Quismorio F, Jr, Gray JD, Horwitz DA. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-b suppress a stimulatory graftversus-host disease with a lupus-like syndrome. J Immunol 2004;172:1531-1539.
75. Allez M, Brimnes J, Dotan I, Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002;123:1516-1526.
76. Ho J, Kurtz CC, Naganuma M, Ernst PB, Cominelli F, Rivera-Nieves J. A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. J Immunol 2008;180: 2573-2580.
77. Izawa A, Yamaura K, Albin MJ, Jurewicz M, Tanaka K, Clarkson MR, Ueno T, Habicht A, Freeman GJ, Yagita H, Abdi R, Pearson T, Greiner DL, Sayegh MH, Najafian N. A novel alloantigen-specific CD8+ PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo. J Immunol 2007;179: 786-796.
78. Najafian N, Chitnis T, Salama AD, Zhu B, Benou C, Yuan X, Clarkson MR, Sayegh MH, Khoury SJ. Regulatory functions of CD8+ CD282 T cells in an autoimmune disease model. J Clin Invest 2003;112:1037-1048.